MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$36,123,615
Interest income
$3,378,545
Other income
(expense)
$200,471
Loss from operations
-$39,702,631
Research and development
$31,856,252
General and
administrative
$7,846,379
Back
Back
Income Statement
source: myfinsight.com
Context Therapeutics Inc. (CNTX)
Context Therapeutics Inc. (CNTX)